2011
DOI: 10.3390/pharmaceutics3040932
|View full text |Cite
|
Sign up to set email alerts
|

Ionic Channels as Targets for Drug Design: A Review on Computational Methods

Abstract: Ion channels are involved in a broad range of physiological and pathological processes. The implications of ion channels in a variety of diseases, including diabetes, epilepsy, hypertension, cancer and even chronic pain, have signaled them as pivotal drug targets. Thus far, drugs targeting ion channels were developed without detailed knowledge of the molecular interactions between the lead compounds and the target channels. In recent years, however, the emergence of high-resolution structures for a plethora of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 134 publications
0
17
0
Order By: Relevance
“…Recently, virtual screening methods have emerged as an efficient approach for identifying potent and specific inhibitors for different ion channels (Langer and Krovat, ; Fernández‐Ballester et al ., ; Simonin et al ., ). In this study, we carried out an initial virtual screening using an in‐house developed pharmacophore similarity search algorithm: xLOS, which compared the spatial overlap between a catalogue of commercially available drug‐like small molecules to the three reference TRPM4 inhibitors, 9‐phenanthrol, glibenclamide and FFA.…”
Section: Discussionmentioning
confidence: 98%
“…Recently, virtual screening methods have emerged as an efficient approach for identifying potent and specific inhibitors for different ion channels (Langer and Krovat, ; Fernández‐Ballester et al ., ; Simonin et al ., ). In this study, we carried out an initial virtual screening using an in‐house developed pharmacophore similarity search algorithm: xLOS, which compared the spatial overlap between a catalogue of commercially available drug‐like small molecules to the three reference TRPM4 inhibitors, 9‐phenanthrol, glibenclamide and FFA.…”
Section: Discussionmentioning
confidence: 98%
“…Modeling was carried out as previously described (22,29,30). Visualization and editing of the molecules were done with Yasara (31) (http:// www.yasara.org).…”
Section: Molecular Modelingmentioning
confidence: 99%
“…2 Potassium channel druggability mechanisms remains an active area of research, for which no single unified mechanism is known. 3 Potassium channels form selective pores that span cell membranes, enabling the selective and rapid conduction of potassium ions down the electrochemical gradient. 4 Their structure comprises two or four subunits, forming dimers of dimers or tetramers.…”
Section: Introductionmentioning
confidence: 99%
“…A pore-loop structure lines the top of the pore, known as the selectivity filter that modulates the selective ion permeability. Currently, at least 60 unique potassium channel X-ray crystal structures are available, 3 of which representatives of three families of potassium channels were considered here.…”
Section: Introductionmentioning
confidence: 99%